top of page


Our team started together at the University of Antwerp in 2019. We  combined our diverse backgrounds across research, engineering, and business to tackle urgent challenges in cancer research. In 2023, we officially incorporated Orbits Oncology in the USA. 

Our mission is to bridge the gap between early cancer research and patients by providing scientists with an advanced analysis platform to transform lab data into digital twins of patient for predicting clinical drug responses.

Meet the Team

bottom of page